Inrebic Den europeiske union - nederlandsk - EMA (European Medicines Agency)

inrebic

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastische middelen - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Rinvoq Den europeiske union - nederlandsk - EMA (European Medicines Agency)

rinvoq

abbvie deutschland gmbh & co. kg - upadacitinib - artritis, reumatoïde - immunosuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Diflucan 40 mg/ml, poeder voor orale suspensie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

diflucan 40 mg/ml, poeder voor orale suspensie

dr. fisher farma b.v. - fluconazol; - poeder voor orale suspensie - fluconazole

Diflucan 40 mg/ml, poeder voor orale suspensie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

diflucan 40 mg/ml, poeder voor orale suspensie

dr. fisher farma b.v. - fluconazol - poeder voor orale suspensie - citroenzuur 0-water (e 330) ; maltodextrine ; natriumbenzoaat (e 211) ; natuurlijk sinaasappelsmaakstof 57.458/ap 05.51 firmenich ; saccharose ; siliciumdioxide (e 551) ; titaandioxide (e 171) ; trinatriumcitraat 2-water (e 331) ; xanthaangom (e 415), - fluconazole

Litfulo Den europeiske union - nederlandsk - EMA (European Medicines Agency)

litfulo

pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - immunosuppressiva - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

Fluconazol Fresenius Kabi 2 mg/ml, oplossing voor infusie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fluconazol fresenius kabi 2 mg/ml, oplossing voor infusie

fresenius kabi nederland b.v. amersfoortseweg 10 e 3712 bc huis ter heide - fluconazol 2 mg/ml - oplossing voor infusie - natriumchloride ; natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - fluconazole

Fluconazol Fresenius Kabi 2 mg/ml inf. opl. i.v. flac. Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fluconazol fresenius kabi 2 mg/ml inf. opl. i.v. flac.

fresenius kabi sa-nv - fluconazol 100 mg/50 ml - oplossing voor infusie - 2 mg/ml - fluconazol 2 mg/ml - fluconazole

Fluconazol Fresenius Kabi 2 mg/ml inf. opl. i.v. flac. Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fluconazol fresenius kabi 2 mg/ml inf. opl. i.v. flac.

fresenius kabi sa-nv - fluconazol 100 mg/50 ml - oplossing voor infusie - 2 mg/ml - fluconazol 2 mg/ml - fluconazole

Fluconazol Fresenius Kabi 2 mg/ml inf. opl. i.v. flac. Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fluconazol fresenius kabi 2 mg/ml inf. opl. i.v. flac.

fresenius kabi sa-nv - fluconazol 100 mg/50 ml - oplossing voor infusie - 2 mg/ml - fluconazol 2 mg/ml - fluconazole

Fluconazol Fresenius Kabi 2 mg/ml inf. opl. i.v. Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fluconazol fresenius kabi 2 mg/ml inf. opl. i.v.

fresenius kabi sa-nv - fluconazol 100 mg/50 ml - oplossing voor infusie - 2 mg/ml - fluconazol 2 mg/ml - fluconazole